Business

MedX Health Corp. Results for the Third Quarter of Fiscal 2013

TSX Venture Symbol: MDX       CUSIP #:   585090 ...

articleMedx Health Corp.November 12, 20135/company/medx-health-corp/news/medx-health-corp-results-for-the-third-quarter-of-fiscal-2013
MedX Health Corp. Results for the Third Quarter of Fiscal 2013

About this update from Medx Health Corp.

[{"type":"text","content":"\n\n\nTSX Venture Symbol: MDX      \n\n\nCUSIP #:   585090\n\n\nMISSISSAUGA, ON, Nov. 12, 2013 /CNW/ - MedX Health Corp. (\"MDX\" or the\n \"Company\") (TSX-V: MDX) reported today its financial and operational\n results for the Third Quarter of fiscal 2013. All amounts are in\n Canadian dollars unless otherwise stated.\n\n\nThird Quarter Financial Highlights\n\n\nThe highlights for MDX, on a consolidated basis, are:\n\n\n\nConsolidated revenue decreased by 37% to $109,000 in Q3 2013 compared to\n $174,000 in Q3 2012;\n\n\nConsolidated Gross Profit decreased 46% to $49,000 in Q3 2013 compared\n to $92,000 in Q3 2012;\n\n\nConsolidated operating expenses decreased by 37% to $412,000 in Q3 2013\n compared to $421,000 in Q3 2012;\n\n\nComprehensive loss before income taxes increased by 10%, to $362,000,000\n in Q3 2013 compared to comprehensive loss of $329,000 in Q3 2012;\n\n\n\nSteve Guillen, CEO, said:  \"The Third Quarter of Fiscal 2013 was another\n tough period and continued to present many challenges while we were in\n the process of changing many aspects of our business strategy.   We\n have significantly developed and re-aligned our strategic approach to\n marketing which we believe will lead to major developments during the\n latter part of fiscal 2013 as we bring our products, especially the\n MoleMate™ units, to the market through new channels.\"\n\n\nHistorical information for the Three month periods ended September 30,\n 2013 and 2012 are as follows: (in $000's except per share figures)\n\n\n\n\n \n\n\nTHREE MONTHS ENDED SEPTEMBER 30\n\n\n\n\n \n\n\n2013\n\n\n2012\n\n\n\n\nRevenues\n\n\n109\n\n\n174\n\n\n\n\nCost of goods sold\n\n\n60\n\n\n81\n\n\n\n\nGross profit\n\n\n49\n\n\n92\n\n\n\n\nExpenses\n\n\n412\n\n\n421\n\n\n\n\nComprehensive loss\n\n\n(362)\n\n\n(329)\n\n\n\n\nPer share (loss)\n\n\n(0.01)\n\n\n(0.01)\n\n\n\n\n\n\n\nConsolidated Unaudited Interim Financial Statements\n\n\nNOTE TO READER: The following unaudited interim financial statements are extracted from\n the complete unaudited interim financial statements of the Company for\n the Three and Nine Months ended September 30, 2013, which have been\n filed on SEDAR together with the Management's Discussion and Analysis.\n References to \"accompanying Notes\" refer to the Notes to the un...

More updates from Medx Health Corp.